These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

304 related items for PubMed ID: 18031373

  • 1. Short and long term efficacy of high intensity focused ultrasound therapy for advanced hepatocellular carcinoma.
    Li YY, Sha WH, Zhou YJ, Nie YQ.
    J Gastroenterol Hepatol; 2007 Dec; 22(12):2148-54. PubMed ID: 18031373
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Clinical effect of transcatheter arterial chemoembolization combined with high intensity focused ultrasound ablation in treatment of large hepatocellular carcinoma].
    Li CX, Wu PH, Fan WJ, Huang JH, Zhang FJ, Zhang L, Gu YK, Zhao M, Gao F, Jiao DC.
    Zhonghua Yi Xue Za Zhi; 2009 Mar 24; 89(11):754-7. PubMed ID: 19595104
    [Abstract] [Full Text] [Related]

  • 4. Therapeutic effects and prognostic factors in high-intensity focused ultrasound combined with chemoembolisation for larger hepatocellular carcinoma.
    Li C, Zhang W, Zhang R, Zhang L, Wu P, Zhang F.
    Eur J Cancer; 2010 Sep 24; 46(13):2513-21. PubMed ID: 20663659
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Follow-up of high-intensity focused ultrasound treatment for patients with hepatocellular carcinoma.
    Xu G, Luo G, He L, Li J, Shan H, Zhang R, Li Y, Gao X, Lin S, Wang G.
    Ultrasound Med Biol; 2011 Dec 24; 37(12):1993-9. PubMed ID: 22036638
    [Abstract] [Full Text] [Related]

  • 8. Advanced hepatocellular carcinoma: treatment with high-intensity focused ultrasound ablation combined with transcatheter arterial embolization.
    Wu F, Wang ZB, Chen WZ, Zou JZ, Bai J, Zhu H, Li KQ, Jin CB, Xie FL, Su HB.
    Radiology; 2005 May 24; 235(2):659-67. PubMed ID: 15858105
    [Abstract] [Full Text] [Related]

  • 9. [The study of clinical application of high intensity focused ultrasound in non-invasive therapy for liver cancer].
    Yi J, Li N, Jiang LS, Xiong XZ.
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2005 May 24; 36(3):426-8. PubMed ID: 15931887
    [Abstract] [Full Text] [Related]

  • 10. Prognostic values of alpha-fetoprotein and protein induced by vitamin K absence or antagonist-II in hepatitis B virus-related hepatocellular carcinoma: a prospective study.
    Kim HS, Park JW, Jang JS, Kim HJ, Shin WG, Kim KH, Lee JH, Kim HY, Jang MK.
    J Clin Gastroenterol; 2009 May 24; 43(5):482-8. PubMed ID: 19197197
    [Abstract] [Full Text] [Related]

  • 11. Survival rates according to the Cancer of the Liver Italian Program scores of 345 hepatocellular carcinoma patients after multimodality treatments during a 10-year period in a retrospective study.
    Yamagiwa K, Shiraki K, Yamakado K, Mizuno S, Hori T, Yagi S, Hamada T, Iida T, Nakamura I, Fujii K, Usui M, Isaji S, Ito K, Tagawa S, Takeda K, Yokoi H, Noguchi T.
    J Gastroenterol Hepatol; 2008 Mar 24; 23(3):482-90. PubMed ID: 18086115
    [Abstract] [Full Text] [Related]

  • 12. Survival analysis of high-intensity focused ultrasound therapy vs. transarterial chemoembolization for unresectable hepatocellular carcinomas.
    Cheung TT, Poon RT, Jenkins CR, Chu FS, Chok KS, Chan AC, Tsang SH, Dai WC, Yau TC, Chan SC, Fan ST, Lo CM.
    Liver Int; 2014 Jul 24; 34(6):e136-43. PubMed ID: 24451026
    [Abstract] [Full Text] [Related]

  • 13. [Clinical observation on high intensity focused ultrasound combined with transcatheter arterial chemoembolization in the treatment of hepatocellular carcinoma].
    Wu Y, Li J, Zhang SJ, Zhao YF, Zhao LS, Ma XX, Feng LS, Fan ZJ.
    Zhonghua Wai Ke Za Zhi; 2012 Aug 24; 50(8):691-4. PubMed ID: 23157899
    [Abstract] [Full Text] [Related]

  • 14. Evaluation of short-term response of high intensity focused ultrasound ablation for primary hepatic carcinoma: utility of contrast-enhanced MRI and diffusion-weighted imaging.
    Zhang Y, Zhao J, Guo D, Zhong W, Ran L.
    Eur J Radiol; 2011 Sep 24; 79(3):347-52. PubMed ID: 20638211
    [Abstract] [Full Text] [Related]

  • 15. Comparison of seven staging systems in cirrhotic patients with hepatocellular carcinoma in a cohort of patients who underwent radiofrequency ablation with complete response.
    Guglielmi A, Ruzzenente A, Pachera S, Valdegamberi A, Sandri M, D'Onofrio M, Iacono C.
    Am J Gastroenterol; 2008 Mar 24; 103(3):597-604. PubMed ID: 17970836
    [Abstract] [Full Text] [Related]

  • 16. Circulating tumor cells in patients with solid malignancy treated by high-intensity focused ultrasound.
    Wu F, Wang ZB, Jin CB, Zhang JP, Chen WZ, Bai J, Zou JZ, Zhu H.
    Ultrasound Med Biol; 2004 Apr 24; 30(4):511-7. PubMed ID: 15121253
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The efficacy for unresectable hepatocellular carcinoma may be improved by transcatheter arterial chemoembolization in combination with a traditional Chinese herbal medicine formula: a retrospective study.
    Yu Y, Lang Q, Chen Z, Li B, Yu C, Zhu D, Zhai X, Ling C.
    Cancer; 2009 Nov 15; 115(22):5132-8. PubMed ID: 19672999
    [Abstract] [Full Text] [Related]

  • 20. Early alpha-fetoprotein response predicts treatment efficacy of antiangiogenic systemic therapy in patients with advanced hepatocellular carcinoma.
    Shao YY, Lin ZZ, Hsu C, Shen YC, Hsu CH, Cheng AL.
    Cancer; 2010 Oct 01; 116(19):4590-6. PubMed ID: 20572033
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.